ResearcherUniversity at Buffalo, State University of New YorkNo recent work listed

Salaheldin S. Hamed

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-7675-3088; OpenAlex author ID A5085195472. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2013: 1 paper

Papers 1

Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells. Co-author DOI 10.1007/s00280-013-2226-6 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Robert M. Straubinger · 1 shared paper, 2013 · strength 0.06
- Paper Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells. DOI 10.1007/s00280-013-2226-6 ↗
William J. Jusko · 1 shared paper, 2013 · strength 0.06
- Paper Pharmacodynamic modeling of cell cycle and apoptotic effects of gemcitabine on pancreatic adenocarcinoma cells. DOI 10.1007/s00280-013-2226-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.